|
Thrombolysis
Citations 51-60 of 839 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Factors Associated With Intracerebral Hemorrhage After Thrombolytic Therapy for Ischemic Stroke. Pooled Analysis of Placebo Data From the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials
- Brett Cucchiara, Scott E. Kasner, David Tanne, Steven R. Levine, Andrew Demchuk, Steven R. Messe, Lauren Sansing, Kennedy R. Lees, Patrick Lyden for the SAINT Investigators
Stroke published July 16, 2009, doi:10.1161/STROKEAHA.109.554386
[Abstract]
- Original Contributions
Gender Differences in Acute Ischemic Stroke: Etiology, Stroke Patterns and Response to Thrombolysis
- Alex Förster, Achim Gass, Rolf Kern, Marc E. Wolf, Caroline Ottomeyer, Katrin Zohsel, Michael Hennerici, and Kristina Szabo
Stroke 2009;40:2428-2432; published online before print as doi:10.1161/STROKEAHA.109.548750
[Abstract]
[Full text]
- Original Contributions
Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial
- Jeffrey L. Saver, Jeffrey Gornbein, James Grotta, David Liebeskind, Helmi Lutsep, Lee Schwamm, Phillip Scott, and Sidney Starkman
Stroke 2009;40:2433-2437; published online before print as doi:10.1161/STROKEAHA.108.543561
[Abstract]
[Full text]
- Original Contributions
Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke: A Metaanalysis
- Maarten G. Lansberg, Erich Bluhmki, and Vincent N. Thijs
Stroke 2009;40:2438-2441; published online before print as doi:10.1161/STROKEAHA.109.552547
[Abstract]
[Full text]
- Original Contributions
Relationship of Blood Pressure, Antihypertensive Therapy, and Outcome in Ischemic Stroke Treated With Intravenous Thrombolysis: Retrospective Analysis From Safe Implementation of Thrombolysis in Stroke–International Stroke Thrombolysis Register (SITS-ISTR)
- Niaz Ahmed, Nils Wahlgren, Michael Brainin, José Castillo, Gary A. Ford, Markku Kaste, Kennedy R. Lees, Danilo Toni for the SITS Investigators
Stroke 2009;40:2442-2449; published online before print as doi:10.1161/STROKEAHA.109.548602
[Abstract]
[Full text]
- Original Contributions
Normobaric Hyperoxia Reduces the Neurovascular Complications Associated With Delayed Tissue Plasminogen Activator Treatment in a Rat Model of Focal Cerebral Ischemia
- Wenlan Liu, Jill Hendren, Xu-Jun Qin, and Ke Jian Liu
Stroke 2009;40:2526-2531; published online before print as doi:10.1161/STROKEAHA.108.545483
[Abstract]
[Full text]
- Research Letters
Knowledge of Tissue Plasminogen Activator for Acute Stroke Among Michigan Adults
- Beth E. Anderson, Ann P. Rafferty, Sarah Lyon-Callo, Chris Fussman, and Mathew J. Reeves
Stroke 2009;40:2564-2567; published online before print as doi:10.1161/STROKEAHA.108.545988
[Abstract]
[Full text]
- Research Letters
Is it Time to Reassess the SITS-MOST Criteria for Thrombolysis?: A Comparison of Patients With and Without SITS-MOST Exclusion Criteria
- Marta Rubiera, Marc Ribo, Estevo Santamarina, Olga Maisterra, Raquel Delgado-Mederos, Pilar Delgado, Gemma Ortega, Jose Alvarez-Sabin, and Carlos A. Molina
Stroke 2009;40:2568-2571; published online before print as doi:10.1161/STROKEAHA.108.538587
[Abstract]
[Full text]
- Research Letters
Clinical–Diffusion Mismatch and Benefit From Thrombolysis 3 to 6 Hours After Acute Stroke
- Martin Ebinger, Takeshi Iwanaga, Jane F. Prosser, Deidre A. De Silva, Soren Christensen, Marnie Collins, Mark W. Parsons, Christopher R. Levi, Christopher F. Bladin, P. Alan Barber, Geoffrey A. Donnan, Stephen M. Davis for the EPITHET Investigators
Stroke 2009;40:2572-2574; published online before print as doi:10.1161/STROKEAHA.109.548073
[Abstract]
[Full text]
- Special Reports
Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials
- Jeffrey L. Saver, Gregory W. Albers, Billy Dunn, Karen C. Johnston, Marc Fisher for the STAIR VI Consortium
Stroke 2009;40:2594-2600; published online before print as doi:10.1161/STROKEAHA.109.552554
[Abstract]
[Full text]
|
|
